Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia

Journal of Nutrition, Health and Aging

Volumn 19, Issue 1, 2015, Pages 77-86

  Filip, R ^a,b   Possemiers, Sam ^c,d   Heyerick, A ^c,d   Pinheiro, I ^e   Raszewski, G ^a   Davicco, M J ^f,g   Coxam, V ^f,g  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c GHENT UNIVERSITY   (Belgium)

^d Witaxos BioActor Bv BioPartner Center   (Netherlands)

^e Formerly at Prodigest   (Belgium)

^f CEMAGREF   (France)

^g UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

bone mineral density; lipid profile; Oleuropein; osteocalcin

Indexed keywords

BIOLOGICAL MARKER; BONOLIVE; IRIDOID; LIPID; OLEUROPEIN; OSTEOCALCIN; PLACEBO; PLANT EXTRACT; POLYPHENOL;

AGED; BLOOD; BONE; BONE DENSITY; BONE DISEASES, METABOLIC; CHEMISTRY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HUMAN; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; OLIVE TREE; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TIME;

AGED; BIOMARKERS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRIDOIDS; LIPIDS; LUMBAR VERTEBRAE; MIDDLE AGED; OLEA; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; PLACEBOS; PLANT EXTRACTS; POLYPHENOLS; POSTMENOPAUSE; TIME FACTORS;

EID: 84940217216     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-014-0480-x     Document Type: Article

References (41)

1. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;7:407–413.
2. Klibanski A, Adams-Campbell L, Bassford T, Blair SN, Boden SD, et al. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–795.
3. Delaney MF. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obst Gynecol 2006;194:S12–S23.
4. Simon LS. Osteoporosis. Clin Geriatr Med 2005;21:603–629.
5. Bharadwaj S, Naidu AG, Betageri GV, Prasadarao NV, Naidu AS. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women. Osteoporos Int 2009;20:1603–1611.
6. Khaltaev N. WHO Scientific group on the assessment of osteoporosis at primary health care level. Brussels, Belgium, 2004.
7. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 2007;22:465–475.
8. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 2011;377:1276–1287.
9. Cramer JA, Amonkar MM, Hebborn A, Altman R. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005;21:1453–1460.
10. Puel C, Coxam V, Davicco M-J. Mediterranean diet and osteoporosis prevention. Med Sci 2007;23:756–760.
11. Tuck KL, Hayball PJ. Major phenolic compounds in olive oil: metabolism and health effects. J Nutr Biochem 2002;13:636–644.
12. Vissers MN, Zock PL, Roodenburg AJC, Leenen R, Katan MB. Olive oil phenols are absorbed in humans. J Nutr 2002;132:409–417.
13. Puel C, Mardon J, Kati-Coulibaly S, Davicco M-J, Lebecque P, et al. Black Lucques olives prevented bone loss caused by ovariectomy and talc granulomatosis in rats. Br J Nutr 2007;97:1012–1020.
14. Puel C, Mathey J, Agalias A, Kati-coulibaly S, Mardon J, et al. Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat. Clin Nutr 2006;25:859–868.
15. Puel C, Quintin A, Agalias A, Mathey J, Obled C, et al. Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat. Br J Nutr 2004;92:119–127.
16. Hagiwara K, Goto T, Araki M, Miyazaki H, Hagiwara H. Olive polyphenol hydroxytyrosol prevents bone loss. Eur J Pharmacol 2011;662:78–84.
17. Saleh NK, Saleh HA. Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats. BMC Complement Altern Med 2011;11: 10.
18. Gong D, Geng C, Jiang L, Wang L, Yoshimura H, et al. Mechanisms of olive leaf extract-ameliorated rat arthritis caused by kaolin and carrageenan. Phytother Res 2012;26:397–402.
19. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, et al. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. J Pharmacol Exp Ther 2011;339:859–869.
20. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137–1141.
21. Lei Z, Xiaoying Z, Xingguo L. Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats. Int J Exp Pathol 2009;90:512–519.
22. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma 2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004;3:379–389.
23. Santiago-Mora R, Casado-Diaz A, De Castro MD, Quesada-Gomez JM. Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow. Osteoporos Int 2011;22:675–684.
24. Drira R, Chen S, Sakamoto K. Oleuropein and hydroxytyrosol inhibit adipocyte differentiation in 3 T3-L1 cells. Life Sci 2011;89:708–716.
25. Dequeker J, Ranstam J, Valsson J, Sigurgevisson B, Allander E, et al. The ai]Mediterranean osteoporosis (MEDOS) study questionnaire. Clin Rheumatol 1991;10:54–72.
26. Tsubono Y, Ogawa K, Watanabe Y, Nishino Y, Tsuji I, et al. Food frequency questionnaire as a screening test. Nutr Cancer 2001;39:78–84.
27. Filip RS, Zagorski J. Osteoporosis risk factors in rural and urban women from the Lublin region of Poland. Ann Agric Environ Med 2005;12:21–26.
28. Karsdal MA, Schett G, Emery P, Harari O, Byrjalsen I, et al. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522). Semin Arthritis Rheum 2012;42:131–139.
29. Kontogianni VG, Gerothanassis IP. Phenolic compounds and antioxidant activity of olive leaf extracts. Nat Prod Res 2012;26:186–189.
30. Radtke J, Linseisen J, Wolfram G. Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Z Ernahrungswiss 1998;37:190–197.
31. Vissers MN, Zock PL, Roodenburg AJ, Leemen R, Katan MB. Apparent absorption of olive oil phenols in humans. J Nutr 2002;132:409–417.
32. Visioli F, Galli C, Bornet F, Mattei A, Patelli R, et al. Olive oil phenolics are dosedependently absorbed in humans. FEBS Lett 2000;468:159–160.
33. Ross CA, Taylor CL, Yaktine AL, Del Valle HB. Dietary reference intakes for calcium and vitamin D. In: Academies IoMoTN, editor. Washington D.C. THE National Academies Press. 2011;pp. 1132.
34. Fernandez-Real MJ, Bullo M, Moreno-Navarrete MJ, Ricart W, Ros E, et al. A Mediterranean diet enriched with olive oil Is associated with higher serum total osteocalcin levels in elderly men at high cardiovascular risk. J Clin Endocrinol Metab 2012;97: 3792–3798.
35. Johnell O, Gullberg B, Allander E, Kanis JA, Dilzen G, et al. The apparent incidence of hip fracture in Europe- a study of National Register Sources. Osteopor Int 1992;2:298–302.
36. Kanis JA. The incidence of hip fracture in Europe. Osteopor Int 1993;3:S10–S15.
37. Coxam V, Puel C, Davicco MJ. Olive and olive oil in the prevention of osteoporosis. In: Preedy VR, Watson RR, editors. Olives and olive oil in health and disease prevention: Academic Press. pp. 2010;1195–1203.
38. Born A-K, Lischer S, Maniura-Weber K. Watching osteogenesis: Life monitoring of osteogenic differentiation using an osteocalcin reporter. J Cell Biochem 2012;113:313–321.
39. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik C. Peroxisome proliferatoractivated receptor gamma (PPAR gamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003;278:962–967.
40. Gimble JM, Nuttall ME. The relationship between adipose tissue and bone metabolism. Clin Biochem 2012;45:874–879.
41. Sarkis KS, Martini LA, Szejnfeld VL, Pinheiro MM. Low fatness, reduced fat intake and adequate plasmatic concentrations of LDL-cholesterol are associated with high bone mineral density in women: a cross-sectional study with control group. Lipids ai]Health Dis 2012;11, 37.